Scientific article
OA Policy
English

Emergence of vancomycin-resistant Enterococcus faecium vanA ST612 with reduced daptomycin susceptibility, Switzerland, 2018 to 2024

Published in

Euro surveillance, vol. 30, no. 45, 2500227

Publication date

2025-11

Abstract

We describe the emergence of vancomycin-resistant Enterococcus faecium (VREfm) vanA ST612 in Switzerland from 2018 to 2024 that resulted in a national outbreak investigation. This clone has predisposing genetic alterations associated with reduced daptomycin susceptibility. The National Nosocomial Outbreak Investigation Center was commissioned to assess the temporospatial distribution of this clone in Switzerland and evaluate its clinical impact. Core genome multi-locus sequence typing (cgMLST) revealed five separate VREfm van A ST612 clusters of different sizes across different healthcare regions, but predominantly in the German-speaking part. The broad geographic dissemination and temporal variation in detection suggests multiple introductions to the healthcare system. One of these cgMLST clusters (n = 79 cases) with an infection rate of 12.8% was ongoing, mainly affecting patients with extensive contact to the Swiss healthcare system or prior antibiotic exposure. The detection of daptomycin non-susceptibility in patients without prior daptomycin exposure suggests ongoing E. faecium adaptation due to external pressures. Future prevention efforts should emphasise assessing barriers for active surveillance cultures, developing a national standard for cost-effective sequencing methods and promoting the sharing of sequencing results together with epidemiological metadata. Our report intends to raise awareness as this sequence type might already be spreading undetected in European countries.

Keywords

  • ST612
  • VRE
  • Daptomycin non susceptibility
  • Emergence
  • Outbreak
  • Risk factor
  • Humans
  • Switzerland / epidemiology
  • Daptomycin / pharmacology
  • Daptomycin / therapeutic use
  • Enterococcus faecium / genetics
  • Enterococcus faecium / drug effects
  • Enterococcus faecium / isolation & purification
  • Gram-Positive Bacterial Infections / epidemiology
  • Gram-Positive Bacterial Infections / microbiology
  • Gram-Positive Bacterial Infections / drug therapy
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Vancomycin-Resistant Enterococci / genetics
  • Vancomycin-Resistant Enterococci / isolation & purification
  • Vancomycin-Resistant Enterococci / drug effects
  • Multilocus Sequence Typing
  • Cross Infection / epidemiology
  • Cross Infection / microbiology
  • Cross Infection / drug therapy
  • Disease Outbreaks
  • Microbial Sensitivity Tests
  • Male
  • Female
  • Middle Aged
  • Aged
  • Adult
  • Vancomycin / pharmacology
  • Bacterial Proteins / genetics
  • Carbon-Oxygen Ligases / genetics

Citation (ISO format)

VUICHARD-GYSIN, Danielle et al. Emergence of vancomycin-resistant Enterococcus faecium vanA ST612 with reduced daptomycin susceptibility, Switzerland, 2018 to 2024. In: Euro surveillance, 2025, vol. 30, n° 45, p. 2500227. doi: 10.2807/1560-7917.ES.2025.30.45.2500227

Main files (1)

Article (Published version)

Secondary files (1)

Appendix

Identifiers

Journal ISSN

1025-496X
17views
163downloads

Technical informations

Creation

03/12/2025 11:15:31

First validation

13/01/2026 11:17:35

Update

29/09/2026 10:36:51

Status update

24/03/2026 09:59:27

Last indexation

10/11/2026 13:29:30
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated